跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
万赛维 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Valganciclovir Hydrochloride Tablets
Approved
化学药品
Valganciclovir Hydrochloride Tablets
Cheplapharm Arzneimittel Gmbh
🇨🇳 National Medical Products Administration
Approval Date
Sep 3, 2024
Approval ID
8cyaXFelZOT
Company
Cheplapharm Arzneimittel Gmbh
Type
化学药品
Approval Details
Approval Id
8cyaXFelZOT
Approval Number
国药准字HJ20150330
Generic Name
盐酸缬更昔洛韦片
Generic Name En
Valganciclovir Hydrochloride Tablets
Trade Name
万赛维
Drug Type
化学药品
Dosage Form
片剂
Strength
0.45g (以缬更昔洛韦计)
Reg Date
2024-09-03
Expired Date
2029-09-02
Company Name
Cheplapharm Arzneimittel Gmbh
Production Company Name
Patheon Inc
Company Detail Path
/organization/cheplapharm-arzneimittel-gmbh
Production Company Detail Path
/organization/patheon-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 3, 2024
Approval ID
8cyaXFelZOT
Type
化学药品
Back to NMPA Approvals